Subclinical and asymptomatic parathyroid disease: implications of emerging data

Keyphrases

• Disease Implications 100%
• Parathyroidectomy 100%
• Primary Hyperparathyroidism (pHPT) 100%
• Parathyroid Disease 100%
• Intact Parathyroid Hormone (iPTH) 66%
• Sporadic Primary Hyperparathyroidism 66%
• Randomized Controlled Trial 33%
• Natural History 33%
• Possible Complications 33%
• On-state Current 33%
• Cardiovascular Outcomes 33%
• Low Risk 33%
• Cardiovascular Mortality 33%
• Cardiovascular Morbidity 33%
• Postmenopausal Women 33%
• Symptomatic Patients 33%
• Working Diagnosis 33%
• Osteoporosis 33%
• Clinical Follow-up 33%
• Medical Surveillance 33%
• Hormone Concentration 33%
• Renal Stone 33%
• Overproduction 33%
• Long-run Risk 33%
• Risk of Progression 33%
• Fracture Risk 33%
• Hyperparathyroidism 33%
• Consensus Guidelines 33%
• Natural Potential 33%
• Hypercalcemia 33%
• Neuropsychological Symptoms 33%
• Patient Progress 33%
• Hypoparathyroidism 33%

Medicine and Dentistry

• Primary Hyperparathyroidism 100%
• Parathyroid Disease 100%
• Disease 60%
• Parathyroidectomy 60%
• Cardiovascular System 40%
• Parathyroid Hormone 40%
• Randomized Controlled Trial 20%
• Observational Study 20%
• Kidney Stone 20%
• Osteoporosis 20%
• Postmenopause 20%
• Hyperparathyroidism 20%
• Hypercalcaemia 20%
• Hypoparathyroidism 20%
• Periodic Medical Examination 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Primary Hyperparathyroidism 100%
• Parathyroid Disease 100%
• Disease 60%
• Parathyroid Hormone 40%
• Nephrolithiasis 20%
• Randomized Controlled Trial 20%
• Observational Study 20%
• Hypercalcaemia 20%
• Hyperparathyroidism 20%
• Hypoparathyroidism 20%
• Kidney Stone 20%